ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
基因編輯
329.32
-6.9443
-2.07%
漲家數:
1
跌家數:
4
平家數:
1
市盈率:
- -
高:
334.90
開:
334.41
低:
325.30
收:
336.26
資料載入中...
總覽
新聞資訊
Sui生態代幣持續拉昇,WAL 24小時漲超16%
Blockbeats
·
4小時前
Editas Medicine, Inc.盤中異動 下午盤股價大跌5.28%
市场透视
·
04-26
Sangamo Therapeutics, Inc.盤中異動 股價大跌5.34%
市场透视
·
04-26
Sui生態代幣出現普漲行情,CETUS 24小時上漲36%
Blockbeats
·
04-25
凱雷集團公司和SK資本第六投資有限責任公司收購藍鳥生物公司股權案無條件批准
金融界
·
04-24
Sangamo Therapeutics, Inc.盤中異動 股價大漲5.08%
市场透视
·
04-23
藍鳥生物盤中異動 股價大漲5.18%報4.57美元
市场透视
·
04-23
Intellia Therapeutics, Inc.盤中異動 大幅拉昇5.17%
市场透视
·
04-23
Beam Therapeutics Inc.盤中異動 快速拉昇5.85%報20.25美元
市场透视
·
04-23
SUI生態代幣普漲,SUI 24小時漲超23%
Blockbeats
·
04-23
Intellia Therapeutics, Inc.盤中異動 下午盤股價大漲5.11%
市场透视
·
04-23
Beam Therapeutics Inc.盤中異動 股價大漲5.04%
市场透视
·
04-23
Crispr Therapeutics Ag盤中異動 股價大漲5.10%報39.75美元
市场透视
·
04-22
藍鳥生物盤中異動 大幅拉昇5.13%報4.10美元
市场透视
·
04-22
藍鳥生物盤中異動 下午盤股價大跌5.07%
市场透视
·
04-22
Editas Medicine, Inc.盤中異動 大幅拉昇5.47%
市场透视
·
04-21
Beam Therapeutics Inc.盤中異動 早盤快速拉昇5.06%報17.86美元
市场透视
·
04-21
Intellia Therapeutics, Inc.盤中異動 大幅上漲5.26%報7.61美元
市场透视
·
04-21
Intellia Therapeutics, Inc.盤中異動 股價大漲5.03%報7.21美元
市场透视
·
04-18
Crispr Therapeutics Ag盤中異動 早盤股價大跌5.04%報36.99美元
市场透视
·
04-16
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4556/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因編輯","latestPrice":329.31583,"timestamp":1745611199999,"preClose":336.2601,"halted":0,"volume":7611124,"delay":0,"changeRate":-0.020651,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-6.944275,"latestTime":"04-25 16:00:00 EDT","open":334.4121,"high":334.89978,"low":325.3,"amount":94011918.391997,"amplitude":0.028549,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.780094,"peRate":-3.548139,"turnoverRate":0.013014,"increases":1,"decrements":4,"flats":1,"marketCap":6451050712,"floatMarketCap":6184357168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":334.89978,"amplitude":0.028549,"preClose":336.2601,"low":325.3,"pbRate":"1.780094","latestPrice":329.31583,"volume":7611124,"delay":0,"open":334.4121,"prevYearClose":376.62552,"prevWeekClose":307.2176,"prevMonthClose":297.7814,"prevQuarterClose":297.7814,"fiveDayClose":307.2176,"twentyDayClose":337.5683,"sixtyDayClose":382.5421,"secType":"PLATE","market":"US","turnoverRate":0.013014,"peRate":-3.548139,"marketCap":6451050712,"floatMarketCap":6184357168,"timestamp":1745611199999,"nameCN":"基因編輯"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":1,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530848490","title":"Sui生態代幣持續拉昇,WAL 24小時漲超16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530848490","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530848490?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:56","pubTimestamp":1745808960,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/291484","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["LU1791807156.HKD","BK4211","BK4556","BK4589","WAL","LU0106831901.USD","DEEP","BLUE","BK4588","BK4585","BK4139","BK4578","LU1668664300.SGD"],"gpt_icon":0},{"id":"2530163397","title":"Editas Medicine, Inc.盤中異動 下午盤股價大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530163397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530163397?lang=zh_tw&edition=fundamental","pubTime":"2025-04-26 01:40","pubTimestamp":1745602845,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日01时40分,Editas Medicine, Inc.股票出现异动,股价急速下挫5.28%。Editas Medicine, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。其相关个股中,Jaguar Health, Inc.、Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Tnf Pharmaceuticals, Inc.、Azitra Inc、Jaguar Health, Inc.较为活跃,换手率分别为284.39%、273.76%、203.44%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为90.48%、90.07%、84.62%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家临床阶段基因组编辑公司,致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426014045aa2c7c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426014045aa2c7c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2530157925","title":"Sangamo Therapeutics, Inc.盤中異動 股價大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530157925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530157925?lang=zh_tw&edition=fundamental","pubTime":"2025-04-26 00:19","pubTimestamp":1745597992,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日00时19分,Sangamo Therapeutics, Inc.股票出现异动,股价快速跳水5.34%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Sangamo Therapeutics, Inc.公司简介:Sangamo Therapeutics Inc是一家基因组医学公司,致力于将突破性的科学转化为药物,以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426001952a6c84202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426001952a6c84202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMO","LENZ","BK4007","BK4556"],"gpt_icon":0},{"id":"2530943063","title":"Sui生態代幣出現普漲行情,CETUS 24小時上漲36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530943063","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530943063?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 09:29","pubTimestamp":1745544540,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/291160","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK4556","BLUE","SCA","BK4139","BK4578"],"gpt_icon":0},{"id":"2529603989","title":"凱雷集團公司和SK資本第六投資有限責任公司收購藍鳥生物公司股權案無條件批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529603989","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529603989?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 18:01","pubTimestamp":1745488902,"startTime":"0","endTime":"0","summary":"4月24日,根据国家市场监管总局公示,2025年4月14日—4月20日共有20件经营者集中案件获无条件批准。其中,凯雷集团公司和SK资本第六投资有限责任公司收购蓝鸟生物公司股权案获无条件批准,审结时间为2025年4月15日。该参与集中的经营者包括:凯雷集团公司,SK资本第六投资有限责任公司,蓝鸟生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042418032894e0d5b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042418032894e0d5b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CG","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BLUE","BK4556","IE00B64PRP62.GBP","BK4139","BK4578"],"gpt_icon":0},{"id":"2529812326","title":"Sangamo Therapeutics, Inc.盤中異動 股價大漲5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529812326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529812326?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:44","pubTimestamp":1745415858,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时44分,Sangamo Therapeutics, Inc.股票出现波动,股价快速拉升5.08%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Instil Bio, Inc.涨幅较大,Ensysce Biosciences, Inc.、Ocean Biomedical, Inc.、Onconetix, Inc.较为活跃,换手率分别为4048.18%、24.99%、21.82%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.,振幅分别为41.18%、39.99%、33.25%。Sangamo Therapeutics, Inc.公司简介:Sangamo Therapeutics Inc是一家基因组医学公司,致力于将突破性的科学转化为药物,以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214418aa2c78ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214418aa2c78ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","LENZ","BK4139","BK4007","SGMO"],"gpt_icon":0},{"id":"2529063344","title":"藍鳥生物盤中異動 股價大漲5.18%報4.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529063344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529063344?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:32","pubTimestamp":1745415170,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时32分,蓝鸟生物股票出现异动,股价快速上涨5.18%。截至发稿,该股报4.57美元/股,成交量3905股,换手率0.04%,振幅3.23%。蓝鸟生物股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为3150.54%、18.95%、9.35%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Ocean Biomedical, Inc.,振幅分别为41.18%、29.61%、15.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321325194dfa798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321325194dfa798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","BLUE","BK4578"],"gpt_icon":0},{"id":"2529268787","title":"Intellia Therapeutics, Inc.盤中異動 大幅拉昇5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529268787?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:31","pubTimestamp":1745415061,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Intellia Therapeutics, Inc.股票出现波动,股价快速上涨5.17%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics 是一家基因编辑公司,致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系,以推进其产品线的发展,其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213101a463f8f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213101a463f8f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4535","BK4585","LU1861559042.SGD","BK4139","NTLA","BK4556","LENZ","BK4007","BK4588"],"gpt_icon":0},{"id":"2529899446","title":"Beam Therapeutics Inc.盤中異動 快速拉昇5.85%報20.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529899446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529899446?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:30","pubTimestamp":1745415050,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分,Beam Therapeutics Inc.股票出现波动,股价急速拉升5.85%。截至发稿,该股报20.25美元/股,成交量3.2606万股,换手率0.03%,振幅0.00%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家生物技术公司,致力于基于其专有的碱基编辑技术开发一类新的精准基因药物,为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213051a6c53c18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213051a6c53c18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4611","BK4556","BK4588","BK4505","BEAM","BK4007","BK4139","BK4535","LENZ"],"gpt_icon":0},{"id":"2529957425","title":"SUI生態代幣普漲,SUI 24小時漲超23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529957425","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529957425?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 08:31","pubTimestamp":1745368260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/290829","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BLUE","BK4215","SCA","BK4556","BK4228","BK4139","SUI","BK4578"],"gpt_icon":0},{"id":"2529558925","title":"Intellia Therapeutics, Inc.盤中異動 下午盤股價大漲5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529558925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529558925?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 02:28","pubTimestamp":1745346519,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日02时28分,Intellia Therapeutics, Inc.股票出现波动,股价急速上涨5.11%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.99%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics 是一家基因编辑公司,致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系,以推进其产品线的发展,其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423022839a462ce50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423022839a462ce50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NTLA","BK4588","LU1861558580.USD","BK4585","LU1861559042.SGD","BK4556","LENZ","BK4535","BK4007","BK4139"],"gpt_icon":0},{"id":"2529669534","title":"Beam Therapeutics Inc.盤中異動 股價大漲5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529669534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529669534?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 00:02","pubTimestamp":1745337751,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时02分,Beam Therapeutics Inc.股票出现波动,股价大幅上涨5.04%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为2.03%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家生物技术公司,致力于基于其专有的碱基编辑技术开发一类新的精准基因药物,为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230002329740de7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230002329740de7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4556","BK4505","BEAM","BK4585","BK4007","BK4588","BK4611","BK4535","BK4139"],"gpt_icon":0},{"id":"2529091581","title":"Crispr Therapeutics Ag盤中異動 股價大漲5.10%報39.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529091581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529091581?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 21:44","pubTimestamp":1745329470,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时44分,Crispr Therapeutics Ag股票出现波动,股价快速上涨5.10%。截至发稿,该股报39.75美元/股,成交量17.2188万股,换手率0.20%,振幅3.33%。Crispr Therapeutics Ag股票所在的生物技术行业中,整体涨幅为1.36%。Crispr Therapeutics Ag公司简介:CRISPR Therapeutics AG是一家基因编辑公司,专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写,是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221443194de362f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221443194de362f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4556","CRSP","LU1861558580.USD","BK4585","LU1861559042.SGD","BK4139","LENZ","BK4007","BK4588"],"gpt_icon":0},{"id":"2529193538","title":"藍鳥生物盤中異動 大幅拉昇5.13%報4.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529193538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529193538?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 21:44","pubTimestamp":1745329444,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时44分,蓝鸟生物股票出现波动,股价急速上涨5.13%。截至发稿,该股报4.10美元/股,成交量2.0484万股,换手率0.21%,振幅4.87%。蓝鸟生物股票所在的生物技术行业中,整体涨幅为1.36%。其相关个股中,60 Degrees Pharmaceuticals, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、阿诺医药涨幅较大,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ibio, Inc.较为活跃,换手率分别为174.74%、95.43%、43.16%,振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals, Inc.、Ibio, Inc.,振幅分别为23.53%、21.49%、18.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222144049740bcc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222144049740bcc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","BLUE","BK4578"],"gpt_icon":0},{"id":"2529319663","title":"藍鳥生物盤中異動 下午盤股價大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529319663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529319663?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 01:46","pubTimestamp":1745257575,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日01时46分,蓝鸟生物股票出现异动,股价快速跳水5.07%。截至发稿,该股报3.93美元/股,成交量3.4246万股,换手率0.35%,振幅4.38%。机构评级方面,在所有5家参与评级的机构中,20%的券商给予买入建议,80%的券商给予持有建议,无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中,整体跌幅为0.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422014615a4615edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422014615a4615edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BLUE","BK4578","BK4139"],"gpt_icon":0},{"id":"2529389678","title":"Editas Medicine, Inc.盤中異動 大幅拉昇5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529389678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529389678?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 22:13","pubTimestamp":1745244825,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时13分,Editas Medicine, Inc.股票出现异动,股价急速上涨5.47%。Editas Medicine, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Editas Medicine, Inc.公司简介:Editas Medicine Inc 是一家临床阶段基因组编辑公司,致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221345aa2c7440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221345aa2c7440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2529002118","title":"Beam Therapeutics Inc.盤中異動 早盤快速拉昇5.06%報17.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529002118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529002118?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 22:09","pubTimestamp":1745244551,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时09分,Beam Therapeutics Inc.股票出现波动,股价快速拉升5.06%。截至发稿,该股报17.86美元/股,成交量19.0309万股,换手率0.19%,振幅6.61%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家生物技术公司,致力于基于其专有的碱基编辑技术开发一类新的精准基因药物,为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4535","BK4556","BK4007","BK4585","BK4588","BEAM","BK4611","BK4139"],"gpt_icon":0},{"id":"2529802975","title":"Intellia Therapeutics, Inc.盤中異動 大幅上漲5.26%報7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529802975?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 21:43","pubTimestamp":1745243018,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时43分,Intellia Therapeutics, Inc.股票出现异动,股价快速上涨5.26%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics 是一家基因编辑公司,致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系,以推进其产品线的发展,其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214339973f752c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214339973f752c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4007","BK4588","BK4556","NTLA","BK4535","LU1861558580.USD","LENZ","LU1861559042.SGD"],"gpt_icon":0},{"id":"2528778867","title":"Intellia Therapeutics, Inc.盤中異動 股價大漲5.03%報7.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778867?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 03:36","pubTimestamp":1744918600,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日03时36分,Intellia Therapeutics, Inc.股票出现波动,股价大幅上涨5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics 是一家基因编辑公司,致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系,以推进其产品线的发展,其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418033641aa2c739c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418033641aa2c739c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4588","LENZ","LU1861559042.SGD","BK4007","BK4535","NTLA","LU1861558580.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2527424952","title":"Crispr Therapeutics Ag盤中異動 早盤股價大跌5.04%報36.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527424952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527424952?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 22:03","pubTimestamp":1744812231,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时03分,Crispr Therapeutics Ag股票出现波动,股价大幅下跌5.04%。截至发稿,该股报36.99美元/股,成交量23.3247万股,换手率0.27%,振幅4.03%。Crispr Therapeutics Ag股票所在的生物技术行业中,整体跌幅为1.39%。Crispr Therapeutics Ag公司简介:CRISPR Therapeutics AG是一家基因编辑公司,专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写,是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220351aa2c718c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220351aa2c718c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4611","BK4007","LU1861558580.USD","CRSP","BK4585","LENZ","BK4556","LU1861559042.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}